Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence

Pancreatic ductal adenocarcinoma (PDAC) is an extraordinarily lethal disease, which, despite a more or less efficient chemotherapeutic treatment, systematically displays a rapid and uncontrolled progression towards a fatal recurrence. Determining which cells give rise to such tumor recurrence is thu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncoscience
Autores principales: Molejon, Maria Inés, Tellechea, Juan Ignacio, Moutardier, Vincent, Gasmi, Mohamed, Ouaissi, Mehdi, Turrini, Olivier, Delpero, Jean-Robert, Dusetti, Nelson, Iovanna, Juan
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2015
Materias:
Research Perspective
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4506359/
https://ncbi.nlm.nih.gov/pubmed/26244163
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares